Louie is a Commercialisation Executive within Imperial Enterprise, supporting inventions arising from the Faculty of Medicine. Louie works largely with academics and technologies in MedTech, Digital Healthcare, AI for Healthcare, and Diagnostic Devices.
He holds a PhD in Veterinary Medicine from the University of Surrey, where he studied the application of a carbon nanotube-based tissue scaffold for iPSC-derived cardiac muscle tissue to facilitate improved cardiac physiology, in vitro electrical stimulation and anti-arrhythmic drug discovery – supported by Advanced Material Development, a nanomaterial innovations company. He also holds a BSc (Hons) in Biochemistry and has experience in pharmaceutical R&D from GlaxoSmithKline and Pfizer.
